BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1247833)

  • 1. Editorial: IUDs and heavy periods.
    Br Med J; 1976 Feb; 1(6005):304. PubMed ID: 1247833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The levonorgestrel-releasing intrauterine device.
    Toivonen J
    Adv Contracept Deliv Syst; 1994; 10(3-4):191-8. PubMed ID: 12287838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IUD-induced uterine bleeding.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some observations on intrauterine contraceptive device (Lippes loop).
    Menon MK
    J Obstet Gynaecol India; 1970 Jun; 20(3):289-97. PubMed ID: 12275251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modes of action of IUDs].
    Janaud A
    Contracept Fertil Sex (Paris); 1982 May; 10(5):343-52. PubMed ID: 12338186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disease and contraception. Recent aspects].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
    Khanna A; Biswas AK; Dubey B; Khanna AK
    Indian J Med Res; 1992 Jun; 96():147-9. PubMed ID: 1512035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial reaction with long use of intrauterine contraceptive devices (7-9 years).
    Hefnawi F; Askalani AH; Hasseeb F; Issa A
    Egypt Popul Fam Plann Rev; 1974 Jun; 7(1):1-10. PubMed ID: 12257563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive overview of intrauterine contraceptive device (IUCD).
    Nnatu S
    J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostaglandins and intrauterine contraceptive device].
    Zhu JH
    Shengzhi Yu Biyun; 1987; 7(1):3-5. PubMed ID: 12341307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic activity in endometrium and uterine fluid of women using intrauterine contraceptive devices].
    Lu Q
    Shengzhi Yu Biyun; 1983 Aug; 3(3):6-8. PubMed ID: 12267402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative cytochemical study of ACP and AKP activity in the endometrial bleeding associated with copper intrauterine devices (IUDs)].
    Huang LL
    Shengzhi Yu Biyun; 1991 Aug; 11(3):22-6. PubMed ID: 12343702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.